The Relationship Between UA/HDL and Diabetic Peripheral Neuropathy: A Cross-Sectional Analysis

References

• Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369:m997. doi:10.1136/bmj.m997
   PubMed Web of Science ®Google Scholar
• Reed J, Bain S, Kanamarlapudi V. A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives. Diabetes Metab Syndr Obes. 2021;14:3567–3602. doi:10.2147/DMSO.S319895
   PubMed Web of Science ®Google Scholar
• Sher EK, Prnjavorac B, Farhat EK, Palić B, Ansar S, Sher F. Effect of diabetic neuropathy on reparative ability and immune response system. Mol Biotechnol. 2023. doi:10.1007/s12033-023-00813-z
   Web of Science ®Google Scholar
• Li C, Wang W, Ji Q, et al. Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: a nationwide cross-sectional study in mainland China. Diabet Res Clin Pract. 2023;198:110602. doi:10.1016/j.diabres.2023.110602
   PubMed Web of Science ®Google Scholar
• Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021;17(7):400–420. doi:10.1038/s41574-021-00496-z
   PubMed Web of Science ®Google Scholar
• Zilliox LA. Diabetes and peripheral nerve disease. Clin Geriatr Med. 2021;37(2):253–267. doi:10.1016/j.cger.2020.12.001
   PubMed Web of Science ®Google Scholar
• Li Z, Gao Y, Jia Y, Chen S. Correlation between hemoglobin glycosylation index and nerve conduction velocity in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2021;14:4757–4765. doi:10.2147/DMSO.S334767
   PubMed Web of Science ®Google Scholar
• Chen X-J, Wang X-F, Pan Z-C. Nerve conduction velocity is independently associated with bone mineral density in type 2 diabetes mellitus. Front Endocrinol. 2023;14:1109322. doi:10.3389/fendo.2023.1109322
   PubMed Web of Science ®Google Scholar
• Castelli G, Desai KM, Cantone RE. Peripheral neuropathy: evaluation and differential diagnosis. Am Fam Physician. 2020;102(12):732–739.
   PubMed Web of Science ®Google Scholar
• Won JC, Park TS. Recent advances in diagnostic strategies for diabetic peripheral neuropathy. Endocrinol Metab. 2016;31(2):230. doi:10.3803/EnM.2016.31.2.230
   Google Scholar
• Sharma S, Rayman G. Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN). Front Endocrinol. 2023;14:1165505. doi:10.3389/fendo.2023.1165505
   PubMed Web of Science ®Google Scholar
• Kırça M, Oğuz N, Çetin A, Uzuner F, Yeşilkaya A. Uric acid stimulates proliferative pathways in vascular smooth muscle cells through the activation of p38 MAPK, p44/42 MAPK and PDGFRβ. J Recept Signal Transduction Res. 2017;37(2):167–173. doi:10.1080/10799893.2016.1203941
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Huang H, Hu X, Zhang J, Cai Q. Serum uric acid and diabetic peripheral neuropathy: a double-edged sword. Acta Neurol Belg. 2023;123(3):857–863. doi:10.1007/s13760-022-01978-1
   PubMed Web of Science ®Google Scholar
• Yu S, Chen Y, Hou X, et al. Serum uric acid levels and diabetic peripheral neuropathy in type 2 diabetes: a systematic review and meta-analysis. Mol Neurobiol. 2016;53(2):1045–1051. doi:10.1007/s12035-014-9075-0
   PubMed Web of Science ®Google Scholar
• Zhang H, Vladmir C, Zhang Z, et al. Serum uric acid levels are related to diabetic peripheral neuropathy, especially for motor conduction velocity of tibial nerve in type 2 diabetes mellitus patients. J Diabetes Res. 2023;2023:3060013. doi:10.1155/2023/3060013
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tang Z, Tong L, Wang Y, Li L. Serum uric acid and risk of diabetic neuropathy: a genetic correlation and Mendelian randomization study. Front Endocrinol. 2023;14:1277984. doi:10.3389/fendo.2023.1277984
   PubMed Web of Science ®Google Scholar
• Piko P, Jenei T, Kosa Z, et al. Association of HDL subfraction profile with the progression of insulin resistance. Int J Mol Sci. 2023;24(17):13563. doi:10.3390/ijms241713563
   PubMed Web of Science ®Google Scholar
• Aktas G, Kocak MZ, Bilgin S, Atak BM, Duman TT, Kurtkulagi O. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23(5):1098–1102. doi:10.1080/13685538.2019.1678126
   PubMed Web of Science ®Google Scholar
• Cheng Y, Zhang H, Zheng H, et al. Association between serum uric acid/HDL-cholesterol ratio and chronic kidney disease: a cross-sectional study based on a health check-up population. BMJ Open. 2022;12(12):e066243. doi:10.1136/bmjopen-2022-066243
   PubMed Web of Science ®Google Scholar
• Xuan Y, Zhang W, Wang Y, et al. Association between uric acid to HDL cholesterol ratio and diabetic complications in men and postmenopausal women. DMSO. 2023;16:167–177. doi:10.2147/DMSO.S387726
   Google Scholar
• Ban J, Pan X, Yang L, et al. Correlation between fibrinogen/albumin and diabetic peripheral neuropathy. Diabetes Metab Syndr Obes. 2023;16:2991–3005. doi:10.2147/DMSO.S427510
   PubMed Web of Science ®Google Scholar
• Javed S, Hayat T, Menon L, Alam U, Malik RA. Diabetic peripheral neuropathy in people with type 2 diabetes: too little too late. Diabet Med. 2020;37(4):573–579. doi:10.1111/dme.14194
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras. 2019;65(1):9–15. doi:10.1590/1806-9282.65.1.9
   PubMed Web of Science ®Google Scholar
• Lin X, Xu L, Zhao D, Luo Z, Pan S. Correlation between serum uric acid and diabetic peripheral neuropathy in T2DM patients. J Neurol Sci. 2018;385:78–82. doi:10.1016/j.jns.2017.11.034
   PubMed Web of Science ®Google Scholar
• Gherghina ME, Peride I, Tiglis M, Neagu TP, Niculae A, Checherita IA. Uric acid and oxidative stress—relationship with cardiovascular, metabolic, and renal impairment. Int J Mol Sci. 2022;23(6):3188. doi:10.3390/ijms23063188
   PubMed Web of Science ®Google Scholar
• Liu Y-P, Shao S-J, Guo H-D. Schwann cells apoptosis is induced by high glucose in diabetic peripheral neuropathy. Life Sci. 2020;248:117459. doi:10.1016/j.lfs.2020.117459
   PubMed Web of Science ®Google Scholar
• Xiong Q, Liu J, Xu Y. Effects of uric acid on diabetes mellitus and its chronic complications. Int J Endocrinol. 2019;2019:1–8. doi:10.1155/2019/9691345
   Web of Science ®Google Scholar
• Chen L, Li B, Chen B, et al. Thymoquinone alleviates the experimental diabetic peripheral neuropathy by modulation of inflammation. Sci Rep. 2016;6(1):31656. doi:10.1038/srep31656
   PubMedGoogle Scholar
• Lu W, Xu Y, Shao X, et al. Uric acid produces an inflammatory response through activation of NF-κB in the hypothalamus: implications for the pathogenesis of metabolic disorders. Sci Rep. 2015;5(1):12144. doi:10.1038/srep12144
   PubMedGoogle Scholar
• Khosla U M, Zharikov S, Finch J L, Nakagawa T, Roncal C, Mu W, Krotova K, Block E R, Prabhakar S and Johnson R J. (2005). Hyperuricemia induces endothelial dysfunction. Kidney International, 67(5), 1739–1742. 10.1111/j.1523-1755.2005.00273.x
   PubMed Web of Science ®Google Scholar
• Choi Y, Yoon Y, Lee K, et al. Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB j. 2014;28(7):3197–3204. doi:10.1096/fj.13-247148
   PubMed Web of Science ®Google Scholar
• Kjeldsen EW, Nordestgaard LT, Frikke-Schmidt R. HDL cholesterol and non-cardiovascular disease: a narrative review. Int J Mol Sci. 2021;22(9):4547. doi:10.3390/ijms22094547
   PubMed Web of Science ®Google Scholar
• Endo Y, Fujita M, Ikewaki K. HDL functions-current status and future perspectives. Biomolecules. 2023;13(1):105. doi:10.3390/biom13010105
   PubMed Web of Science ®Google Scholar
• Smith AG, Singleton JR. Obesity and hyperlipidemia are risk factors for early diabetic neuropathy. J diabet complicat. 2013;27(5):436–442. doi:10.1016/j.jdiacomp.2013.04.003
   Google Scholar
• Hur J, Dauch JR, Hinder LM, et al. The metabolic syndrome and microvascular complications in a murine model of type 2 diabetes. Diabetes. 2015;64(9):3294–3304. doi:10.2337/db15-0133
   PubMed Web of Science ®Google Scholar
• Luo L, Zhou WH, Cai JJ, et al. Gene expression profiling identifies downregulation of the neurotrophin-MAPK signaling pathway in female diabetic peripheral neuropathy patients. J Diabetes Res. 2017;2017:1–11. doi:10.1155/2017/8103904
   Web of Science ®Google Scholar
• Kandimalla R, Dash S, Kalita S, et al. Bioactive Fraction Of Annona Reticulata Bark (or) Ziziphus jujuba Root Bark along with insulin attenuates painful diabetic neuropathy through inhibiting NF-κB inflammatory cascade. Front Cell Neurosci. 2017;11. doi:10.3389/fncel.2017.00073
   PubMed Web of Science ®Google Scholar
• Pai YW, Lin CH, Lee IT, Chang MH. Variability of fasting plasma glucose and the risk of painful diabetic peripheral neuropathy in patients with type 2 diabetes. Diabetes Metabolism. 2018;44(2):129–134. doi:10.1016/j.diabet.2018.01.015
   PubMed Web of Science ®Google Scholar